drugset / Trial / NCT01544894
Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to compare compliance and efficacy of raloxifene and strontium ranelate in a group of women with postmenopausal osteoporosis.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Raloxifene | Other / unclassified | 60 mg | — |
| Comparator | Strontium Ranelate | Small molecule | 2 g | — |